FDA Drug Application (079246) for ABACAVIR SULFATE AND LAMIVUDINE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number079246
Product Number001
FormTABLET;ORAL
DosageEQ 600MG BASE;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameABACAVIR SULFATE AND LAMIVUDINE
Active IngredientABACAVIR SULFATE; LAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR SULFATE9
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by TEVA PHARMS USA